Sort
21,453 grants matching “tuberculosis”
Mycobacterium tuberculosis proliferation and its regulation
$357,500Buka Samten · University Of Texas Hlth Ctr At Tyler · R56 · FY2015 · AI
Impact of Ketone Metabolites on Inflammasome Deactivation in Gout
$357,445Vishwa Deep Dixit · Yale University · R01 · FY2021 · AR
Characterization of Pupylation in Mycobacterium tuberculosis
$357,435Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2013 · AI
HIV, Alcohol and TB Pleurisy
$357,380University Of Florida · R21 · FY2004 · AA
Oral Pathogens and Dendritic Cell Subsets
$357,351Christopher W Cutler · State University New York Stony Brook · R01 · FY2010 · DE
Innovative approaches for tuberculosis control in Brazil
$357,320Jose Roberto Lapa E Silva · Federal University Of Rio De Janeiro · U2R · FY2009 · TW
Project 3. Defining the RNA processing and degradation pathways of Mtb.
$357,310Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Inter-American Training for Innovations in Emerging Infectious Diseases
$357,282Richard A Oberhelman · Tulane University Of Louisiana · D43 · FY2012 · TW
Development of a Cell-Based HTS for Inhibitors of Inflammatory Macrophages
$357,230David G Russell · Cornell University · R01 · FY2013 · AI
Identification of ID93+GLA-SE biomarkers for prevention of recurrent TB
$357,200Rhea N Coler · Access To Advanced Health Institute · R21 · FY2016 · AI
Role of N-alpha acetylation in mycobacterial secretion and virulence
$357,200Patricia A Champion · University Of Notre Dame · R01 · FY2013 · AI
Pathogenic Mycobacterial Proteins in Sarcoidosis
$357,195David R Moller · Johns Hopkins University · R01 · FY2008 · HL
T32: Pathogenesis of Infectious Diseases Training Program
$357,155Roy M Gulick · Weill Medical Coll Of Cornell Univ · T32 · FY2015 · AI
Biosynthesis of nucleoside antibiotics targeting bacterial translocase
$356,996Steven Gary Van Lanen · University Of Kentucky · R01 · FY2014 · AI
Inhaled Caprazamycin for Tuberculolsis Therapy
$356,973Anthony James Hickey · Research Triangle Institute · R01 · FY2013 · AI
Biogenesis of lipoarabinomannan in mycobacteria
$356,936Mary Jackson · Colorado State University · R01 · FY2007 · AI
Role of gamma/delta T cells in Vaccine Induced Immunity
$356,913Daniel F. Hoft · Saint Louis University · R01 · FY2010 · AI
Biogenesis of lipoarabinomannan in mycobacteria
$356,888Patrick Joseph Brennan · Colorado State University · R01 · FY2006 · AI
Structure, Function and Inhibition of [4Fe-4S] Proteins
$356,850Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2016 · GM
Structure, Function and Inhibition of [4Fe-4S] Proteins
$356,850Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2014 · GM
Structure, Function and Inhibition of [4Fe-4S] Proteins
$356,850Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2017 · GM
Structure, Function and Inhibition of [4Fe-4S] Proteins
$356,850Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2015 · GM
Analysis of Host-Pathogen Interactions
$356,820Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
NEW MEXICO FIVE-YEAR CYCLE PROPOSAL TO FUND TUBERCULOSIS PREVENTION & CONTROL
$356,791Diana Fortune · New Mexico State Department Of Health · U52 · FY2013 · PS
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
$356,641Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2022 · AI